Clinical Research Directory
Browse clinical research sites, groups, and studies.
Middle East Study of Infections in Patients With Hematological Malignancies
Sponsor: Hamad Medical Corporation
Summary
The goal of this prospective observational study is to is to prospectively study the epidemiology of bloodstream infection (BSI) in patients with hematological malignancies (HM) and hematopoietic stem cell transplant (HSCT) recipients across the Middle East. The objectives are to describe the epidemiological trends, identify risk factors for inappropriate antimicrobial therapy, and predictors of persistent BSI, microbiological relapse, and all-cause mortality. The study is entirely observational, participants will receive standard clinical care as directed by their treating doctors.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-09-15
Completion Date
2028-12-31
Last Updated
2026-10-30
Healthy Volunteers
No
Interventions
No Intervention: Observational Cohort
The study does not involve any investigational interventions. Participants will receive standard clinical care.
Locations (9)
King Hussein Cancer Center
Amman, Jordan
Royal Hospital
Muscat, Oman
Hamad Medical Corporation
Doha, Qatar
King Fahad Specialist Hospital
Dammam, Saudi Arabia
King Abdullah International Medical Research Center
Jeddah, Saudi Arabia
King Faisal Specialist Hospital and Research Center, Jeddah
Jeddah, Saudi Arabia
King Faisal Specialist Hospital and Research Center, Riyadh
Riyadh, Saudi Arabia
Sheikh Shakbout Medical City
Abu Dhabi, United Arab Emirates
Rashid Hospital
Dubai, United Arab Emirates